title: Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism.
abstract: Considering that platelet response to thrombin receptor activation might be critical for the development of arterial thrombosis, we measured the dense granule release under stimulation by the thrombin receptor activating peptide (TRAP) in a series of 102 healthy volunteers. The threshold TRAP concentration which initiated a secretion ranged from 3 to 20 microM. A good concordance (79%, k=0.677) between two tests performed at a 1 month interval indicated that platelet response to thrombin receptor activation was characteristic of each individual donor. Since the threshold concentration required to initiate secretion corresponded to the threshold concentration which induced a biphasic aggregation, all volunteers were genotyped for the PlA2 polymorphism, the Pro33 variant of GPIIIa. Platelets from subjects with the PlA2 polymorphism required higher TRAP concentrations to aggregate than those from subjects with no PlA2 allele (P=0.0012). However, they also required a higher ADP concentration to aggregate. In order to exclude any influence of GPIIIa polymorphism on TRAP-induced secretion, we studied the variability of platelet response to TRAP among the 77 individuals with no PlA2 allele, and found the same interdonor variability with the same distribution of threshold TRAP concentrations as for the 102 individuals. The results suggest that (i) platelet secretion in response to thrombin receptor activation could be a genetically controlled phenotype independent of the GPIIIa polymorphism; (ii) the PlA2 polymorphism is associated with platelet hypoaggregability.
authors.affiliation: Laboratoire d'Hémostase, Hôpital Broussais, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Lasne
authors.forename: M
authors.initials: M
authors.lastname: Krenn
authors.forename: V
authors.initials: V
authors.lastname: Pingault
authors.forename: E
authors.initials: E
authors.lastname: Arnaud
authors.forename: J N
authors.initials: JN
authors.lastname: Fiessinger
authors.forename: M
authors.initials: M
authors.lastname: Aiach
authors.forename: F
authors.initials: F
authors.lastname: Rendu
mesh_terms: D001792:Blood Platelets / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D010446:Peptide Fragments / Q000494:pharmacology*; D017396:Plasminogen Activator Inhibitor 2 / Q000235:genetics*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000235:genetics*; D011110:Polymorphism, Genetic; D018179:Receptors, Thrombin / Q000378:metabolism*
chemical_list: D010446:Peptide Fragments; D017396:Plasminogen Activator Inhibitor 2; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D018179:Receptors, Thrombin; C082835:thrombin receptor peptide (42-47)